Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR Axis. | Int J Mol Sci | 2023 | 37108067 | PubTator, text mining | PubMed |
| Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy. | Adv Sci (Weinh) | 2023 | 37096846 | PubTator, text mining | PubMed |
| Bone Lesion-Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5-Targeting miR-3190-5p. | Adv Sci (Weinh) | 2023 | 37096833 | PubTator, text mining | PubMed |
| Characterization of the m6A regulator-mediated methylation modification patterns in oral squamous cell carcinoma. | Sci Rep | 2023 | 37095314 | PubTator, text mining | PubMed |
| Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. | Cell Death Dis | 2023 | 37095108 | PubTator, text mining | PubMed |
| m6A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression. | Epigenetics | 2023 | 37092305 | PubTator, text mining | PubMed |
| Exploring m6A-RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome. | Pulm Circ | 2023 | 37091123 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients. | Biosci Rep | 2023 | 37083719 | PubTator, text mining | PubMed |
| Identification of a m6A-related ferroptosis signature as a potential predictive biomarker for lung adenocarcinoma. | BMC Pulm Med | 2023 | 37072786 | PubTator, text mining | PubMed |
| METTL3 Mediates Epithelial-Mesenchymal Transition by Modulating FOXO1 mRNA N6 -Methyladenosine-Dependent YTHDF2 Binding: A Novel Mechanism of Radiation-Induced Lung Injury. | Adv Sci (Weinh) | 2023 | 37072646 | PubTator, text mining | PubMed |
| The diverse role of RNA methylation in esophageal cancer. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37070847 | PubTator, text mining | PubMed |
| Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications. | Biomark Res | 2023 | 37069649 | PubTator, text mining | PubMed |
| The Proteins of mRNA Modification: Writers, Readers, and Erasers. | Annu Rev Biochem | 2023 | 37068770 | PubTator, text mining | PubMed |
| YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer. | J Thorac Dis | 2023 | 37065597 | PubTator, text mining | PubMed |
| A novel pyroptosis-related model for prognostic prediction in esophageal squamous cell carcinoma: a bioinformatics analysis. | J Thorac Dis | 2023 | 37065557 | PubTator, text mining | PubMed |
| Regulation of ncRNAs involved with ferroptosis in various cancers. | Front Genet | 2023 | 37065473 | PubTator, text mining | PubMed |
| The essential roles of small non-coding RNAs and RNA modifications in normal and malignant hematopoiesis. | Front Mol Biosci | 2023 | 37065445 | PubTator, text mining | PubMed |
| Bibliometric and visual analysis of RAN methylation in cardiovascular disease. | Front Cardiovasc Med | 2023 | 37063953 | PubTator, text mining | PubMed |
| LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression. | Int J Biol Sci | 2023 | 37063420 | PubTator, text mining | PubMed |
| The m6A-regulation and single cell effect pattern in sunitinib resistance on clear cell renal cell carcinoma: Identification and validation of targets. | Front Pharmacol | 2023 | 37063301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=57